Insider trades
James Mulay, Director of CG Oncology CGON, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $2.2M. The latest trade was on 06/15.
James Mulay
Director
- Company
- CG Oncology CGON
- First filing
- 24/10/07
- Trades
- 42 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- −$2.2M
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
CGON | Open-market sale10b5-1 plan | 06/15 | 06/16 | 1,964 sh2 trades | $60.12avg. | $118,075.68 | −100.0% |
CG OncologyCGON | Open-market sale10b5-1 plan | 04/17 | 04/20 | 15,600 sh | $73.01 | $1,138,956 | −100.0% |
CGON | Open-market sale10b5-1 plan | 03/16 | 03/17 | 1,964 sh2 trades | $63.50avg. | $124,714 | −100.0% |
CGON | Open-market sale10b5-1 plan | 01/09 | 01/13 | 11,145 sh2 trades | $52.47avg. | $584,798.73 | −100.0% |
CG OncologyCGON | Open-market sale10b5-1 plan | 25/10/09 | 25/10/10 | 5,903 sh | $43.99 | $259,672.97 | −100.0% |
CG OncologyCGON | Open-market sale10b5-1 plan | 25/09/29 | 25/09/30 | 12,755 sh | $39.19 | $499,868.45 | −100.0% |
CGON | Open-market sale10b5-1 plan | 25/09/18–25/09/19 | 25/09/22 | 22,686 sh2 trades | $39.01avg. | $884,909.38 | −100.0% |
CGON | Open-market sale10b5-1 plan | 25/09/05 | 25/09/08 | 27,015 sh4 trades | $31.53avg. | $851,797.1 | −100.0% |